Literature DB >> 20467214

A historical perspective on the discovery of statins.

Akira Endo1.   

Abstract

Cholesterol is essential for the functioning of all human organs, but it is nevertheless the cause of coronary heart disease. Over the course of nearly a century of investigation, scientists have developed several lines of evidence that establish the causal connection between blood cholesterol, atherosclerosis, and coronary heart disease. Building on that knowledge, scientists and the pharmaceutical industry have successfully developed a remarkably effective class of drugs--the statins--that lower cholesterol levels in blood and reduce the frequency of heart attacks.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20467214      PMCID: PMC3108295          DOI: 10.2183/pjab.86.484

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  60 in total

1.  Effects of diet on blood lipids in man, particularly cholesterol and lipoproteins.

Authors:  A KEYS; J T ANDERSON; F FIDANZA; M H KEYS; B SWAHN
Journal:  Clin Chem       Date:  1955-02       Impact factor: 8.327

2.  Mechanism of action of MER-29, an inhibitor of cholesterol biosynthesis.

Authors:  J AVIGAN; D STEINBERG; M J THOMPSON; E MOSETTIG
Journal:  Biochem Biophys Res Commun       Date:  1960-01       Impact factor: 3.575

3.  ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium.

Authors:  A Endo; M Kuroda; Y Tsujita
Journal:  J Antibiot (Tokyo)       Date:  1976-12       Impact factor: 2.649

4.  Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

Authors:  A Endo; Y Tsujita; M Kuroda; K Tanzawa
Journal:  Eur J Biochem       Date:  1977-07-01

5.  Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Authors:  Y Tsujita; M Kuroda; K Tanzawa; N Kitano; A Endo
Journal:  Atherosclerosis       Date:  1979-03       Impact factor: 5.162

Review 6.  Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy.

Authors:  Daniel Steinberg
Journal:  J Lipid Res       Date:  2006-04-03       Impact factor: 5.922

7.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

8.  Therapeutic effects of ML-236B in primary hypercholesterolemia.

Authors:  A Yamamoto; H Sudo; A Endo
Journal:  Atherosclerosis       Date:  1980-03       Impact factor: 5.162

9.  Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals.

Authors:  A Endo; Y Tsujita; M Kuroda; K Tanzawa
Journal:  Biochim Biophys Acta       Date:  1979-11-21

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  102 in total

Review 1.  Natural product discovery: past, present, and future.

Authors:  Leonard Katz; Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2016-01-06       Impact factor: 3.346

Review 2.  Importance of microbial natural products and the need to revitalize their discovery.

Authors:  Arnold L Demain
Journal:  J Ind Microbiol Biotechnol       Date:  2013-08-30       Impact factor: 3.346

Review 3.  Red yeast rice for dysipidemia.

Authors:  Shariq Shamim; Firas J Al Badarin; James J DiNicolantonio; Carl J Lavie; James H O'Keefe
Journal:  Mo Med       Date:  2013 Jul-Aug

4.  In vitro Anti-Tumor Effects of Statins on Head and Neck Squamous Cell Carcinoma: A Systematic Review.

Authors:  Ludmila Madeira Cardoso Pavan; Daniela Fortunato Rêgo; Silvia Taveira Elias; Graziela De Luca Canto; Eliete Neves Silva Guerra
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

5.  All, some or none? Statin prescribing for frail older adults.

Authors:  Sudeep S Gill
Journal:  CMAJ       Date:  2019-01-14       Impact factor: 8.262

6.  Biomarker identification for statin sensitivity of cancer cell lines.

Authors:  Vineet K Raghu; Colin H Beckwitt; Katsuhiko Warita; Alan Wells; Panayiotis V Benos; Zoltán N Oltvai
Journal:  Biochem Biophys Res Commun       Date:  2017-11-14       Impact factor: 3.575

7.  Repositioning "old" drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion.

Authors:  Esha T Shah; Akanksha Upadhyaya; Lisa K Philp; Tiffany Tang; Dubravka Skalamera; Jennifer Gunter; Colleen C Nelson; Elizabeth D Williams; Brett G Hollier
Journal:  Clin Exp Metastasis       Date:  2016-03-01       Impact factor: 5.150

Review 8.  Hit and lead criteria in drug discovery for infectious diseases of the developing world.

Authors:  Kei Katsuno; Jeremy N Burrows; Ken Duncan; Rob Hooft van Huijsduijnen; Takushi Kaneko; Kiyoshi Kita; Charles E Mowbray; Dennis Schmatz; Peter Warner; B T Slingsby
Journal:  Nat Rev Drug Discov       Date:  2015-10-05       Impact factor: 84.694

Review 9.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

10.  Crowdsourcing natural products discovery to access uncharted dimensions of fungal metabolite diversity.

Authors:  Lin Du; Andrew J Robles; Jarrod B King; Douglas R Powell; Andrew N Miller; Susan L Mooberry; Robert H Cichewicz
Journal:  Angew Chem Int Ed Engl       Date:  2013-11-27       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.